Sentence examples for formulation of antioxidant from inspiring English sources

IIR mediators showed different expression patterns in DED patients, and these patterns changed in response to a combined formulation of antioxidant and EPUFAs supplementation.

The successful ability of niosomal carriers to transport through BBB and the capability of niosomes in encapsulation of both hydrophilic and lipophilic compounds provided our rational for designing of niosomal formulation of antioxidant of vitamin C and E for brain delivery in preventing stroke.

53– 55 Therefore, we analyzed whether a combined formulation of antioxidants and long-chain EPUFAs may influence the evolution of DEDs.

To analyze whether a combined formulation of antioxidants and long-chain EPUFAs may improve the evolution of DEDs.

Our objective was to determine the effects of oral supplementation with a combined formulation of antioxidants and essential polyunsaturated fatty acids on expression of cytokines and chemokines in tears from patients with DEDs or primary open-angle glaucoma (POAG).

We found that oral supplementation with a combined formulation of antioxidants and EPUFAs significantly changed the expression pattern of cytokines/chemokines in tears from DED patients when compared with DED patients not taking the supplements.

39 In the present study, we evaluated the relationship between oral supplementation of a combined formulation of antioxidants and EPUFAs on the improvement of the signs and symptoms of patients diagnosed with nonsevere DEDs, as compared to DED patients not taking these supplements and healthy controls.

To describe the long-term effects (10 years) of the Age-Related Eye Disease Study (AREDS) fofmulation of high-dose antioxidants and zinc supplement on progression of age-related macular degeneration (AMD).

The methanol extract proved to be the most effective among the three extracts used and thus support the use of the plant in formulation of new antimicrobial and antioxidant drugs.

From Neighbor-Joining Cluster analysis based on TMA, TP and FRAP, Figure 5, it can be noticed two clusters, one cluster joining the jam formulations that maintain the highest levels of antioxidant parameters (Cluster I) and the second cluster revealing the formulations with largest loss of desired antioxidant properties (Cluster II).

Addition of antioxidant preservatives to store the pharmaceutical formulation was not necessary.